OmniAb, Inc. (OABI)
4.66
-0.05
(-1.06%)
USD |
NASDAQ |
Aug 25, 11:02
OmniAb Profit Margin (Quarterly) : -43.68% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.68% |
| March 31, 2026 | -53.42% |
| December 31, 2025 | -169.3% |
| September 30, 2025 | -738.1% |
| June 30, 2025 | -407.4% |
| March 31, 2025 | -438.1% |
| December 31, 2024 | -121.0% |
| September 30, 2024 | -392.4% |
| June 30, 2024 | -179.0% |
| March 31, 2024 | -498.8% |
| Date | Value |
|---|---|
| December 31, 2023 | -291.4% |
| September 30, 2023 | -287.3% |
| June 30, 2023 | -212.0% |
| March 31, 2023 | -36.05% |
| December 31, 2022 | 19.30% |
| September 30, 2022 | -182.3% |
| June 30, 2022 | -142.7% |
| March 31, 2022 | -65.28% |
| December 31, 2021 | -20.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 5.90% |
| Champions Oncology, Inc. | -4.82% |
| Medpace Holdings, Inc. | 17.16% |
| Charles River Laboratories International, Inc. | -0.08% |
| Avantor, Inc. | 2.25% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.65% |
| Return on Assets | -14.54% |
| Return on Invested Capital | -15.47% |
| Gross Profit Margin (Quarterly) | 64.01% |
| Operating Margin (Quarterly) | -48.36% |
| Return on Net Operating Assets | -18.12% |